反応 #45127
ord-30be1c6cc8ef46d7a2a6678d5a3c7f62
反応方程式
反応物
試薬
なし
溶媒
反応条件
詳細条件
See reaction.notes.procedure_details.
後処理
- 1その他N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(1-prop-2-ynylpiperidin-4-yl)benzamide was prepared
- 2その他The crude product was purified by silica column chromatography
- 3洗浄eluting with a gradient of 0 to 5% 2.5M ammonia/methanol in DCM
- 4その他Pure fractions were evaporated to dryness
- 5その他the product crystallised from DCM/diethyl ether
実験手順
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(1-prop-2-ynylpiperidin-4-yl)benzamide was prepared following the procedure as outlined for Example 99, starting from methyl 4-(1-prop-2-ynylpiperidin-4-yl)benzoate (0.257 g, 1.00 mmol) and 5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-amine (0.247 g, 1 mmol) in dry toluene (10 mL) with 2M trimethylaluminium (1.250 mL, 2.50 mmol). The crude product was purified by silica column chromatography, eluting with a gradient of 0 to 5% 2.5M ammonia/methanol in DCM. Pure fractions were evaporated to dryness and the product crystallised from DCM/diethyl ether to give the title compound (0.245 g, 51.8%) as a white solid.